Abstract
Primary central nervous system vasculitis is an uncommon disorder of unknown cause that is limited to the brain and spinal cord. The median age of onset is 50 years. The neurological manifestations are diverse, but commonly include headache, altered cognition, focal weakness, or stroke. Serological markers of inflammation are usually normal. Cerebrospinal fluid is abnormal in approximately 80–90 % of the cases. The diagnosis is unlikely in the presence of a normal magnetic resonance imaging (MRI) of the brain. Biopsy of central nervous system tissue showing vasculitis is the only definitive test, however angiography has often been used for diagnosis even though it has only moderate sensitivity and specificity. The size of the vessels involved is varied and influences outcomes and response to treatment. Early recognition is important because treatment with corticosteroids, with or without cytotoxic drugs, may prevent serious outcomes. The differential diagnosis includes reversible cerebral vasoconstriction syndromes and secondary cerebral vasculitis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Salvarani C, Giannini C, Miller DV, Hunder G (2006) Giant cell arteritis: involvement of intracranial arteries. Arthritis Rheum 55:985–989
Cravioto H, Feigin I (1959) Noninfectious granulomatous angiitis with a predilection for the nervous system. Neurology 9:599–609
Salvarani C, Brown RD Jr, Calamia KT, Christianson TJ, Weigand SD, Miller DV, Giannini C, Meschia JF, Huston J 3rd, Hunder GG (2007) Primary central nervous system vasculitis: analysis of 101 patients. Ann Neurol 62:442–451
Moore PM (1989) Diagnosis and management of isolated angiitis of the central nervous system. Neurology 39:167–173
Salvarani C, Brown RD Jr, Calamia KT et al (2008) Angiography-negative primary central nervous system vasculitis: a syndrome involving small cerebral vessels. Medicine (Baltimore) 87:264–271
Salvarani C, Brown RD Jr, Calamia KT et al (2008) Primary central nervous system vasculitis with prominent leptomeningeal enhancement: a subset with a benign outcome. Arthritis Rheum 58:595–603
Salvarani C, Brown RD Jr, Calamia KT et al (2008) Primary central nervous system vasculitis: comparison of patients with and without cerebral amyloid angiopathy. Rheumatology (Oxford) 47:1671–1677
Salvarani C, Brown RD Jr, Calamia KT et al (2011) Rapidly progressive primary central nervous system vasculitis. Rheumatology (Oxford) 50:349–358
Salvarani C, Brown RD Jr, Calamia KT et al (2011) Primary central nervous system vasculitis presenting with intracranial hemorrhage. Arthritis Rheum 63:3598–3606
Salvarani C, Brown RD Jr, Morris JM et al (2014) Catastrophic primary central nervous system vasculitis. Clin Exp Rheumatol 32(Suppl 82):S3–S4
Salvarani C, Brown RD Jr, Hunder GG (2012) Adult primary central nervous system vasculitis. Lancet 380(9843):767–777
Salvarani C, Brown RD Jr, Hunder GG (2012) Adult primary central nervous system vasculitis: an update. Curr Opin Rheumatol 24:46–52
Calabrese LH, Mallek JA (1988) Primary angiitis of the central nervous system. Report of 8 new cases, review of the literature, and proposal for diagnostic criteria. Medicine (Baltimore) 67:20–39
Kadkhodayan Y, Alreshaid A, Moran CJ, Cross DT 3rd, Powers WJ, Derdeyn CP (2004) Primary angiitis of the central nervous system at conventional angiography. Radiology 233:878–882
Duna GF, Calabrese LH (1995) Limitations of invasive modalities in the diagnosis of primary angiitis of the central nervous system. J Rheumatol 22:662–667
Eleftheriou D, Cox T, Saunders D, Klein NJ, Brogan PA, Ganesan V (2010) Investigation of childhood central nervous system vasculitis: magnetic resonance angiography versus catheter cerebral angiography. Dev Med Child Neurol 52(9):863–867
Küker W, Gaertner S, Nagele T, Dopfer C, Schoning M, Fiehler J, Rothwell PM, Herrlinger U (2008) Vessel wall contrast enhancement: a diagnostic sign of cerebral vasculitis. Cerebrovasc Dis 26:23–29
Salvarani C, Brown RD Jr, Huston J 3rd, Hunder GG (2008) Prominent perivascular enhancement in primary central nervous system vasculitis. Clin Exp Rheumatol 26(3 Suppl 49):S111
Swartz RH, Bhuta SS, Farb RI, Agid R, Willinsky RA, Terbrugge KG, Butany J, Wasserman BA, Johnstone DM, Silver FL, Mikulis DJ (2009) Intracranial arterial wall imaging using high-resolution 3-tesla contrast-enhanced MRI. Neurology 72:627–634
Miller DV, Salvarani C, Hunder GG, Brown RD, Parisi JE, Christianson TJ, Giannini C (2009) Biopsy findings in primary angiitis of the central nervous system. Am J Surg Pathol 33:35–43
Salvarani C, Brown RD Jr, Calamia KT, Christianson TJ, Huston J 3rd, Meschia JF, Giannini C, Miller DV, Hunder GG (2008) Primary CNS vasculitis with spinal cord involvement. Neurology 70:2394–2400
Salvarani C, Hunder GG, Morris JM et al (2013) Aβ-related angiitis: comparison with CAA without inflammation and primary CNS vasculitis. Neurology 81:1596–1603
Salvarani C, Brown RD Jr, Christianson T et al (2015) An update of the Mayo Clinic cohort of patients with adult primary central nervous system vasculitis: description of 163 patients. Medicine (Baltimore) 94(21):e738. doi:10.1097/MD.0000000000000738
Giannini C, Salvarani C, Hunder G, Brown RD (2012) Primary central nervous system vasculitis: pathology and mechanisms. Acta Neuropathol 123:759–772
Molloy ES, Singhal AB, Calabrese LH (2008) Tumour-like mass lesion: an under-recognised presentation of primary angiitis of the central nervous system. Ann Rheum Dis 67:1732–1735
Ducros A, Bousser MG (2009) Reversible cerebral vasoconstriction syndrome. Pract Neurol 9:256–267
Cupps TR, Moore PM, Fauci AS (1983) Isolated angiitis of the central nervous system. Prospective diagnostic and therapeutic experience. Am J Med 74:97–105
Salvarani C, Brown RD Jr, Calamia KT, Huston J 3rd, Meschia JF, Giannini C, Miller DV, Hunder GG (2008) Efficacy of tumor necrosis factor alpha blockade in primary central nervous system vasculitis resistant to immunosuppressive treatment. Arthritis Rheum 59:291–296
De Boysson H, Arquizan C, Guillevin L, Pagnoux C (2013) Rituximab for primary angiitis of the central nervous system: report of 2 patients from the French COVAC cohort and review of the literature. J Rheumatol 40:2102–2103
Salvarani C, Brown RD Jr, Huston J 3rd et al (2014) Treatment of primary central nervous system vasculitis with rituximab: case report. Neurology 82:1287–1288
Salvarani C, Brown RD Jr, Christianson TJ et al (2015) Adult primary central nervous system vasculitis treatment and course: analysis of one hundred sixty-three patients. Arthritis Rheumatol 67:1637–1645
Salvarani C, Brown RD Jr, Christianson TJ et al (2015) Mycophenolate mofetil in primary central nervous system vasculitis. Semin Arthritis Rheum 45:55–59
Hutchinson C, Elbers J, Halliday W et al (2010) Treatment of small vessel primary CNS vasculitis in children: an open-label cohort study. Lancet Neurol 9:1078–1084
Sen ES, Leone V, Abinun M et al (2010) Treatment of primary angiitis of the central nervous system in childhood with mycophenolate mofetil. Rheumatology (Oxford) 49:806–811
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Salvarani, C., Brown, R.D., Giannini, C., Hunder, G.G. (2016). Adult Primary Central Nervous System Vasculitis. In: Dammacco, F., Ribatti, D., Vacca, A. (eds) Systemic Vasculitides: Current Status and Perspectives. Springer, Cham. https://doi.org/10.1007/978-3-319-40136-2_22
Download citation
DOI: https://doi.org/10.1007/978-3-319-40136-2_22
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-40134-8
Online ISBN: 978-3-319-40136-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)